Table 1.

Clinical features of selected case reports of hemorrhagic myositis in inflammatory myopathies.

Author	Age (yrs) (at event)	Gender	Clinical history and prebleeding therapies	Antibody profile	Site of bleeding(s)	Treatment	Outcome (as reported)
Orrell et al. [7]	50	Female	DM age 34 Corticosteroid Azathioprine IVIG	None specified	Left rectus abdominis	Blood transfusions Prednisone Azathioprine	Survived, no recurrent bleeding
Orrell et al. [7]	11	Female	DM age 8 Prednisone	ANA 1 : 320 speckled	Retroperitoneum, posterior to right ascending colon	Supportive	Survived without recurrence
Fang et al. [8]	65	Female	PM age 65 Hydrocortisone Prednisone	ANA 1 : 320 speckled	Retroperitoneum, superior duodenal pancreatic artery, SMA	Angiography with embolization	Expired from sepsis without rebleeding
Yamagishi et al. [9]	64	Female	DM/ILD age 64 Solumedrol Prednisone Cyclosporine Dalteparin	ANA positive Elevated serum KL-6	Retroperitoneum, right psoas, right iliacus, left rectus sheath	Angiography with embolization with rebleeding and repeat embolization	Expired from TTP and multiorgan failure
Higashi et al. [10]	77	Female	DM age 77 Solumedrol Prednisone Cyclosporine Heparin	Elevated serum KL-6	Retroperitoneum, left iliopsoas, left iliacus, right sternomastoid	Supportive	Expired from DIC
Van Gelder et al.	50	Male	DM/ILD age 50 Solumedrol IVIG	Anti-Ro52	Retroperitoneum, right iliacus, right psoas	Transfusions Solumedrol	Expired from multiorgan failure
Van Gelder et al.	63	Female	DM/ILD age 63 Solumedrol IVIG	Anti-SSA Anti-Ro52	Retroperitoneum, right pectineus, right iliopsoas	Transfusions Solumedrol Cytoxan	Expired from multiorgan failure